Metropolis Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431M Buy
910,564
+602,264
+195% +$255M 12.5% 2
2026
Q1
$146M Sell
308,300
-172,379
-36% -$86.8M 4.93% 10
2025
Q4
$224M Sell
480,679
-195,071
-29% -$90.6M 7.17% 8
2025
Q3
$288M Buy
675,750
+72,721
+12% +$28.2M 9.06% 3
2025
Q2
$231M Buy
603,029
+261,592
+77% +$94.3M 7.33% 6
2025
Q1
$118M Buy
+341,437
New +$110M 4.38% 11
2020
Q1
Sell
-552,165
Closed -$81.6M 13
2019
Q4
$81.6M Buy
552,165
+80,462
+17% +$10.8M 11.34% 4
2019
Q3
$56.8M Buy
471,703
+124,993
+36% +$16.2M 11.36% 5
2019
Q2
$46.9M Buy
346,710
+108,200
+45% +$13.7M 10.74% 6
2019
Q1
$31.1M Buy
238,510
+128,277
+116% +$17.2M 8.74% 7
2018
Q4
$13.7M Buy
+110,233
New +$14.8M 5.13% 8

Other funds holding HCA

Metropolis Capital's HCA Position: Q2 2026 in Review

Metropolis Capital increased its HCA Healthcare (HCA) stake by 195% in Q2 2026, buying an estimated $255M and bringing the position to 910,564 shares worth $431M. The position accounts for 12.5% of the portfolio, ranked #2.

Metropolis Capital first reported a position in HCA in Q4 2018 and has held it in 11 quarters since. 257 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Metropolis Capital held 910,564 shares of HCA Healthcare worth $431M as of Q2 2026.
  • Metropolis Capital bought 602,264 HCA Healthcare shares in Q2 2026, an estimated $255M.
  • HCA Healthcare made up 12.5% of Metropolis Capital's portfolio in Q2 2026, its #2 holding.
  • Metropolis Capital first reported a position in HCA Healthcare in Q4 2018 and has held it in 11 quarters since.
  • 257 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Metropolis Capital's 13F filing for Q2 2026, filed 22 Jul 2026.